首页 | 本学科首页   官方微博 | 高级检索  
     


Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia
Authors:Ángeles Mencía  Marta García  Eva García  Sara Llames  Alexandra Charlesworth  Raúl de Lucas  Asunción Vicente  María José Trujillo‐Tiebas  Pablo Coto  Marta Costa  Ángel Vera  Arantxa López‐Pestaña  Rodolfo Murillas  Guerrino Meneguzzi  José Luis Jorcano  Claudio J Conti  María José Escámez Toledano  Marcela del Río Nechaevsky
Affiliation:1. Department of Bioengineering, Tissue Engineering and Regenerative Medicine Group (TERMeG), Universidad Carlos III de Madrid, Madrid, Spain;2. Regenerative Medicine Unit, Centro de Investigaciones Energética Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain;3. Instituto de Investigación Sanitaria de la Fundación Jimenez Diaz (IIS‐FJD), Madrid, Spain;4. Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain;5. Laboratorio de Ingeniería de Tejidos, Centro Comunitario de Sangre y Tejidos de Asturias (CCST) Asturias, Oviedo, Spain;6. French Reference Centre for Inherited Epidermolysis Bullosa, L'Archet Hospital, Nice, Cedex3, France;7. Sección de Dermatología, Hospital Universitario La Paz, Madrid, Spain;8. Servicio de Dermatología, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain;9. Instituto de Investigación Sanitaria de la Fundación Jimenez Diaz (IIS‐FJD), Hospital Universitario Jiménez Díaz, Madrid, Spain;10. Servicio de Dermatología y Neonatología, Hospital Universitario Central de Asturias, Oviedo, Spain;11. Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, Spain;12. Servicio de Dermatología, Hospital Donostia, Gipuzkoa, Spain;13. INSERM U1081, CNRS UMR7284, University of Nice, Sophia Antipolis, Faculty of Medicine, Nice, France
Abstract:Epidermolysis bullosa with pyloric atresia (EB‐PA) is a rare autosomal recessive hereditary disease with a variable prognosis from lethal to very mild. EB‐PA is classified into Simplex form (EBS‐PA: OMIM #612138) and Junctional form (JEB‐PA: OMIM #226730), and it is caused by mutations in ITGA6, ITGB4 and PLEC genes. We report the analysis of six patients with EB‐PA, including two dizygotic twins. Skin immunofluorescence epitope mapping was performed followed by PCR and direct sequencing of the ITGB4 gene. Two of the patients presented with non‐lethal EB‐PA associated with missense ITGB4 gene mutations. For the other four, early postnatal demise was associated with complete lack of β4 integrin due to a variety of ITGB4 novel mutations (2 large deletions, 1 splice‐site mutation and 3 missense mutations). One of the deletions spanned 278 bp, being one of the largest reported to date for this gene. Remarkably, we also found for the first time a founder effect for one novel mutation in the ITGB4 gene. We have identified 6 novel mutations in the ITGB4 gene to be added to the mutation database. Our results reveal genotype–phenotype correlations that contribute to the molecular understanding of this heterogeneous disease, a pivotal issue for prognosis and for the development of novel evidence‐based therapeutic options for EB management.
Keywords:epidermolysis bullosa  genodermatoses  inherited skin diseases  ITGB4 mutations  pyloric atresia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号